These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 24582549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ, Ren M, Jiang HZ, Wang J, Zhang J, Yin X, Wang SY, Qi Y, Wang XD, Feng HL.
    Neuroscience; 2014 Sep 26; 277():132-8. PubMed ID: 24699224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway.
    Hu Q, Ren J, Li G, Wu J, Wu X, Wang G, Gu G, Ren H, Hong Z, Li J.
    Cell Death Dis; 2018 Mar 14; 9(3):403. PubMed ID: 29540694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.
    Young ML, Franklin JL.
    Mol Cell Neurosci; 2019 Dec 14; 101():103409. PubMed ID: 31521745
    [Abstract] [Full Text] [Related]

  • 10. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A mice.
    Scaricamazza S, Salvatori I, Amadio S, Nesci V, Torcinaro A, Giacovazzo G, Primiano A, Gloriani M, Candelise N, Pieroni L, Loeffler JP, Renè F, Quessada C, Tefera TW, Wang H, Steyn FJ, Ngo ST, Dobrowolny G, Lepore E, Urbani A, Musarò A, Volonté C, Ferraro E, Coccurello R, Valle C, Ferri A.
    Br J Pharmacol; 2022 Apr 14; 179(8):1732-1752. PubMed ID: 34783031
    [Abstract] [Full Text] [Related]

  • 11. Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle.
    Sakellariou GK, Pearson T, Lightfoot AP, Nye GA, Wells N, Giakoumaki II, Griffiths RD, McArdle A, Jackson MJ.
    FASEB J; 2016 Nov 14; 30(11):3771-3785. PubMed ID: 27550965
    [Abstract] [Full Text] [Related]

  • 12. ALS-associated mutation SOD1G93A leads to abnormal mitochondrial dynamics in osteocytes.
    Wang H, Yi J, Li X, Xiao Y, Dhakal K, Zhou J.
    Bone; 2018 Jan 14; 106():126-138. PubMed ID: 29030231
    [Abstract] [Full Text] [Related]

  • 13. Mitoquinone alleviates vincristine-induced neuropathic pain through inhibiting oxidative stress and apoptosis via the improvement of mitochondrial dysfunction.
    Chen XJ, Wang L, Song XY.
    Biomed Pharmacother; 2020 May 14; 125():110003. PubMed ID: 32187955
    [Abstract] [Full Text] [Related]

  • 14. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
    Dashdorj A, Jyothi KR, Lim S, Jo A, Nguyen MN, Ha J, Yoon KS, Kim HJ, Park JH, Murphy MP, Kim SS.
    BMC Med; 2013 Aug 06; 11():178. PubMed ID: 23915129
    [Abstract] [Full Text] [Related]

  • 15. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
    Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF.
    Free Radic Biol Med; 2008 Dec 01; 45(11):1559-65. PubMed ID: 18845241
    [Abstract] [Full Text] [Related]

  • 16. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.
    Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, Zhou J.
    PLoS One; 2013 Dec 01; 8(12):e82112. PubMed ID: 24324755
    [Abstract] [Full Text] [Related]

  • 17. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R, Li B, Flanagan SW, Oberley LW, Gozal D, Qiu M.
    J Neurochem; 2002 Feb 01; 80(3):488-500. PubMed ID: 11905995
    [Abstract] [Full Text] [Related]

  • 18. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V, Krull D, Taylor A, Dick JR, Bates SA, Cleveland MS, Prinjha RK, Greensmith L.
    Hum Mol Genet; 2014 Aug 15; 23(16):4187-200. PubMed ID: 24667415
    [Abstract] [Full Text] [Related]

  • 19. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
    Gioscia-Ryan RA, LaRocca TJ, Sindler AL, Zigler MC, Murphy MP, Seals DR.
    J Physiol; 2014 Jun 15; 592(12):2549-61. PubMed ID: 24665093
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion 56Fe radiation induced brain injury in mice.
    Gan L, Wang Z, Si J, Zhou R, Sun C, Liu Y, Ye Y, Zhang Y, Liu Z, Zhang H.
    Toxicol Appl Pharmacol; 2018 Feb 15; 341():1-7. PubMed ID: 29317239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.